Нестероидные противовоспалительные препараты при остеоартрите и неспецифической боли в спине: основные положения по эффективному и безопасному применению (междисциплинарный консенсус)

Междисциплинарным советом ведущих специалистов представлены рекомендации для эффективного и безопасного применения в общей амбулаторной практике нестероидных противовоспалительных препаратов при остеоартрите и неспецифической боли в спине.

1. Александрова ГА, Ахметзянова РР, Голубев НА и др. Здравоохранение в России. 2023: Статистический сборник. Москва: Росстат; 2023. 179 с.

2. Насонов ЕЛ, Яхно НН, Каратеев АЕ и др. Общие принципы лечения скелетно-мышечной боли: междисциплинарный консенсус. Научно-практическая ревматология. 2016;54(3):247-265.

3. Парфенов ВА, Яхно НН, Кукушкин МЛ и др. Острая неспецифическая (скелетномышечная) поясничная боль. Рекомендации Российского общества по изучению боли (РОИБ). Неврология, нейропсихиатрия, психосоматика. 2018;10(2):4-11. doi: 10.14412/2074-2711- 2018-2-4-11.

4. Лила АМ, Алексеева ЛИ. Современные подходы к ведению больных остеоартритом в реальной клинической практике. Клиническая медицина. 2023;(2-3):141-146.

5. Scheuing WJ, Reginato AM, Deeb M, Acer Kasman S. The burden of osteoarthritis: Is it a rising problem? Best Pract Res Clin Rheumatol. 2023 Jun;37(2):101836. doi: 10.1016/j.berh.2023.101836. Epub 2023 Aug 24.

6. Chen S, Chen M, Wu X, et al. Global, regional and national burden of low back pain 1990–2019: A systematic analysis of the Global Burden of Disease study 2019. J Orthop Translat. 2021 Sep 10:32:49-58. doi: 10.1016/j.jot.2021.07.005. eCollection 2022 Jan.

7. Crookes T, Wall C, Byrnes J, et al. Chronic shoulder pain. Aust J Gen Pract. 2023 Nov; 52(11):753-758. doi: 10.31128/AJGP-04-23-6790.

8. Veronese N, Cooper C, Bruyere O, et al. Multimodal Multidisciplinary Management of Patients with Moderate to Severe Pain in Knee Osteoarthritis: A Need to Meet Patient Expectations. Drugs. 2022 Sep;82(13): 1347-1355. doi: 10.1007/s40265-022-01773-5. Epub 2022 Sep 16.

9. Nicol V, Verdaguer C, Daste C, et al. Chronic Low Back Pain: A Narrative Review of Recent International Guidelines for Diagnosis and Conservative Treatment. J Clin Med. 2023 Feb 20;12(4):1685. doi: 10.3390/jcm12041685.

10. Cohen SP, Vase L, Hooten WM. Chronic pain: an update on burden, best practices, and new advances. Lancet. 2021 May 29;397(10289): 2082-2097. doi: 10.1016/S0140-6736(21)00393-7.

11. Wood MJ, Miller RE, Malfait AM. The Genesis of Pain in Osteoarthritis: Inflammation as a Mediator of Osteoarthritis Pain. Clin Geriatr Med. 2022 May;38(2):221-238. doi: 10.1016/j.cger.2021.11.013.

12. Fitzcharles MA, Cohen SP, Clauw DJ, et al. Nociplastic pain: towards an understanding of prevalent pain conditions. Lancet. 2021 May 29;397(10289):2098-2110. doi: 10.1016/S0140-6736(21)00392-5.

13. Cohen SP, Mora J. Chronic pain, disease and mortality: Will we follow the path of Noah or Pharaoh? Reg Anesth Pain Med. 2021 Sep; 46(9):743-744. doi: 10.1136/rapm-2021-102949. Epub 2021 Jun 24.

14. Fayaz A, Ayis S, Panesar SS, et al. Assessing the relationship between chronic pain and cardiovascular disease: A systematic review and meta-analysis. Scand J Pain. 2016 Oct:13: 76-90. doi: 10.1016/j.sjpain.2016.06.005. Epub 2016 Aug 3.

15. Veronese N, Cereda E, Maggi S, et al. Osteoarthritis and mortality: A prospective cohort study and systematic review with metaanalysis. Semin Arthritis Rheum. 2016 Oct; 46(2):160-167. doi: 10.1016/j.semarthrit.2016.04.002. Epub 2016 Apr 13.

16. Leyland KM, Gates LS, Sanchez-Santos MT, et al. Knee osteoarthritis and time-to all-cause mortality in six communitybased cohorts: an international meta-analysis of individual participant-level data. Aging Clin Exp Res. 2021 Mar;33(3):529-45. doi: 10.1007/s40520-020-01762-2. Epub 2021 Feb 15.

17. de Luca K, Tavares P, Yang H, et al. Spinal pain, chronic health conditions and health behaviors: Data from the 2016–2018 national health interview survey. Int J Environ Res Public Health. 2023 Apr 3;20(7):5369. doi: 10.3390/ijerph20075369.

18. Freeman R, Wallace MS, Sweeney M, Backonja MM. Relationships Among Pain Quality, Pain Impact, and Overall Improvement in Patients with Postherpetic Neuralgia Treated with Gastroretentive Gabapentin. Pain Med. 2015 Oct;16(10):2000-11. doi: 10.1111/pme.12791. Epub 2015 Jun 25.

19. Barthel HR, Peniston JH, Clark MB, et al. Correlation of pain relief with physical function in hand osteoarthritis: randomized controlled trial post hoc analysis. Arthritis Res Ther. 2010;12(1):R7. doi: 10.1186/ar2906. Epub 2010 Jan 11.

20. Pavelka K, Peliskovа Z, Stehlikova H, et al. Intraindividual differences in pain relief and functional improvement in osteoarthritis with diclofenac or tramadol. Clin Drug Investig. 1998;16(6):421-9. doi: 10.2165/00044011-199816060-00002.

21. Alfuth M, Welsink DW. Pain and functional outcomes after outpatient physiotherapy in patients with low back pain. Orthopade. 2017 Jun;46(6):522-529. doi: 10.1007/s00132-017-3390-x.

22. Peloso PM, Moore RA, Chen WJ, et al. Osteoarthritis patients with pain improvement are highly likely to also have improved quality of life and functioning. A post hoc analysis of a clinical trial. Scand J Pain. 2016 Oct;13: 175-181. doi: 10.1016/j.sjpain.2016.07.002. Epub 2016 Aug 10.

23. Каратеев АЕ, Насонов ЕЛ, Ивашкин ВТ и др. Рациональное использование нестероидных противовоспалительных препаратов. Клинические рекомендации. Научно-практическая ревматология. 2018; 56(S1):1-29.

24. Gerard B, Bailly F, Trouvin AP. How to treat chronic pain in rheumatic and musculoskeletal diseases (RMDs) – A pharmacological review. Joint Bone Spine. 2024 Jan;91(1): 105624. doi: 10.1016/j.jbspin.2023.105624. Epub 2023 Jul 24.

25. Nadeau SE, Lawhern RA. Management of chronic non-cancer pain: A framework. Pain Manag. 2022 Sep;12(6):751-777. doi: 10.2217/pmt-2022-0017. Epub 2022 Jun 1.

26. Ribeiro H, Rodrigues I, Napoleгo L, et al. Non-steroidal anti-inflammatory drugs (NSAIDs), pain and aging: Adjusting prescription to patient features. Biomed Pharmacother. 2022 Jun:150:112958. doi: 10.1016/j.biopha.2022.112958. Epub 2022 Apr 19.

27. da Costa BR, Pereira TV, Saadat P, et al. Effectiveness and safety of non-steroidal antiinflammatory drugs and opioid treatment for knee and hip osteoarthritis: network metaanalysis. BMJ. 2021 Oct 12;375:n2321. doi: 10.1136/bmj.n2321.

28. Cashin AG, Wand BM, O'Connell NE, et al. Pharmacological treatments for low back pain in adults: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2023 Apr 4;4(4):CD013815. doi: 10.1002/14651858.CD013815.pub2.

29. Smith SR, Deshpande BR, Collins JE, et al. Comparative pain reduction of oral nonsteroidal anti-inflammatory drugs and opioids for knee osteoarthritis: systematic analytic review. Osteoarthritis Cartilage. 2016 Jun;24(6): 962-72. doi: 10.1016/j.joca.2016.01.135.

30. O'Donnell JB, Ekman EF, Spalding WM, et al. The effectiveness of a weak opioid medication versus a cyclo-oxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug in treating flare-up of chronic low-back pain: results from two randomized, doubleblind, 6-week studies. J Int Med Res. 2009 Nov-Dec;37(6):1789-802. doi: 10.1177/147323000903700615.

31. https://cr.minzdrav.gov.ru/recomend/778_1

32. https://cr.minzdrav.gov.ru/recomend/667_1

33. Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019 Nov;27(11):1578-1589. doi: 10.1016/j.joca.2019.06.011. Epub 2019 Jul 3.

34. Bruyere O, Honvo G, Veronese N, et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum. 2019 Dec;49(3):337- 350. doi: 10.1016/j.semarthrit.2019.04.008. Epub 2019 Apr 30.

35. Atkinson TJ, Fudin J. Nonsteroidal Antiinflammatory Drugs for Acute and Chronic Pain. Phys Med Rehabil Clin N Am. 2020 May; 31(2):219-231. doi: 10.1016/j.pmr.2020.01.002. Epub 2020 Mar 10.

36. Gupta A, Bah M. NSAIDs in the Treatment of Postoperative Pain. Curr Pain Headache Rep. 2016 Nov;20(11):62. doi: 10.1007/s11916-016-0591-7.

37. Shatsky М. Evidence for the use of intramuscular injections in outpatient practice. Fam Physician. 2009 Feb 15;79(4):297-300.

38. Sproviero E, Albamonte E, Costantino C, et al. Efficacy and safety of a fixed combination of intramuscular diclofenac 75 mg + thiocolchicoside 4 mg in the treatment of acute low back pain: a phase III, randomized, double blind, controlled trial. Eur J Phys Rehabil Med. 2018 Oct;54(5):654-662. doi: 10.23736/S1973-9087.17.04923-1. Epub 2017 Dec 21.

39. Zippel H, Wagenitz A. A multicentre, randomised, double-blind study comparing the efficacy and tolerability of intramuscular dexketoprofen versus diclofenac in the symptomatic treatment of acute low back pain. Clin Drug Investig. 2007;27(8):533-43. doi: 10.2165/00044011-200727080-00002.

40. Babej-Dölle R, Freytag S, Eckmeyer J, et al. Parenteral dipyrone versus diclofenac and placebo in patients with acute lumbago or sciatic pain: randomized observer-blind multicenter study. Int J Clin Pharmacol Ther. 1994 Apr;32(4):204-9.

41. Алексеев ВВ, Подчуфарова ЕВ. Применение мелоксикама (мовалиса) в лечении люмбоишиалгического синдрома. Боль. 2004;(4):49-53.

42. Каратеев АЕ, Лила АМ, Погожева ЕЮ и др. Факторы, влияющие на эффективность применения нестероидных противовоспалительных препаратов при острой боли в нижней части спины. Результаты многоцентрового наблюдательного иссле дования «КАРАМБОЛЬ» (Клинический Анализ Результатов Аналгезии Мелоксикамом и его Безопасности при Острой Люмбалгии). Современная ревматология. 2019;13(2):31-37. doi: 10.14412/1996-7012-2019-2-31-37

43. Zeng C, Wei J, Persson MSM, et al. Relative efficacy and safety of topical nonsteroidal anti-inflammatory drugs for osteoarthritis: a systematic review and network meta-analysis of randomised controlled trials and observational studies. Br J Sports Med. 2018 May;52(10):642-650. doi: 10.1136/bjsports-2017-098043. Epub 2018 Feb 7.

44. Derry S, Wiffen PJ, Kalso EA, et al. Topical analgesics for acute and chronic pain in adults – an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2017 May 12;5: CD008609. doi: 10.1002/14651858.CD008609.pub2.

45. Khankhel N, Friedman BW, Baer J, et al. Topical Diclofenac Versus Oral Ibuprofen Versus Diclofenac + Ibuprofen for Emergency Department Patients With Acute Low Back Pain: A Randomized Study. Ann Emerg Med. 2024 Jun;83(6):542-551. doi: 10.1016/j.annemergmed.2024.01.037.

46. Serinken M, Eken C, Tunay K, Golcuk Y. Ketoprofen gel improves low back pain in addition to IV dexketoprofen: a randomized placebo-controlled trial. Am J Emerg Med. 2016 Aug;34(8):1458-61. doi: 10.1016/j.ajem.2016.04.028. Epub 2016 Apr 22.

47. Allegrini A, Nuzzo L, Pavone D, et al. Efficacy and safety of piroxicam patch versus piroxicam cream in patients with lumbar osteoarthritis. A randomized, placebo-controlled study. Arzneimittelforschung. 2009; 59(8):403-9. doi: 10.1055/s-0031-1296415.

48. Honvo G, Leclercq V, Geerinck A, et al. Safety of Topical Non-steroidal Anti-Inflammatory Drugs in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis. Drugs Aging. 2019 Apr;36(Suppl 1):45-64. doi: 10.1007/s40266-019-00661-0.

49. Peniston JH, Gold MS, Wieman MS, Alwine LK. Long-term tolerability of topical diclofenac sodium 1% gel for osteoarthritis in seniors and patients with comorbidities. Clin Interv Aging. 2012;7:517-23. doi: 10.2147/CIA.S35416. Epub 2012 Nov 20.

50. Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochem Pharmacol. 2020 Oct;180: 114147. doi: 10.1016/j.bcp.2020.114147. Epub 2020 Jul 10.

51. LaForge JM, Urso K, Day JM, et al. Nonsteroidal Anti-inflammatory Drugs: Clinical Implications, Renal Impairment Risks, and AKI. Adv Ther. 2023 May;40(5):2082-2096. doi: 10.1007/s12325-023-02481-6. Epub 2023 Mar 22.

52. Новикова ДС, Удачкина ЕВ, Попкова ТВ, Лила АМ. Рациональное использование нестероидных противовоспалительных препаратов у больных ревматоидным артритом с точки зрения сердечно-сосудистой безопасности. РМЖ. Медицинское обозрение. 2019;11(II):64-70.

53. Zeng C, Doherty M, Persson MSM, et al. Comparative efficacy and safety of acetaminophen, topical and oral non-steroidal anti-inflammatory drugs for knee osteoarthritis: Evidence from a network meta-analysis of randomized controlled trials and real-world data. Osteoarthritis Cartilage. 2021 Sep;29(9):1242- 1251. doi: 10.1016/j.joca.2021.06.004. Epub 2021 Jun 24.

54. Aw TJ, Haas SJ, Liew D, Krum H. Metaanalysis of cyclooxygenase-2 inhibitors and their effects on blood pressure. Arch Intern Med. 2005 Mar 14;165(5):490-6. doi: 10.1001/archinte.165.5.IOI50013. Epub 2005 Feb 14.

55. Villa J, Cano A, Franco D, et al. Clinical relevance of drug interactions between nonsteroidal antiinflammatory drugs (NSAIDs) and antihypertensives. Aten Primaria. 2014 Nov;46(9):464-74. doi: 10.1016/j.aprim.2013.11.010. Epub 2014 Mar 22.

56. Ungprasert P, Srivali N, Kittanamongkolchai W. Non-steroidal anti-inflammatory drugs and risk of heart failure exacerbation: A systematic review and meta-analysis. Eur J Intern Med. 2015 Nov;26(9):685-90. doi: 10.1016/j.ejim.2015.09.012. Epub 2015 Oct 1.

57. Bhala N, Emberson J, Merhi A, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: Metaanalyses of individual participant data from randomised trials. Lancet. 2013 Aug 31; 382(9894):769-79. doi: 10.1016/S0140-6736(13)60900-9. Epub 2013 May 30.

58. Shi C, Ye Z, Shao Z, et al. Multidisciplinary Guidelines for the Rational Use of Topical Non-Steroidal Anti-Inflammatory Drugs for Musculoskeletal Pain (2022). Clin Med. 2023 Feb 15;12(4):1544. doi: 10.3390/jcm12041544.

59. Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019 Nov;27(11):1578-1589. doi: 10.1016/j.joca.2019.06.011. Epub 2019 Jul 3.

60. Brophy RH, Fillingham YA. AAOS Clinical Practice Guideline Summary: Management of Osteoarthritis of the Knee (Nonarthroplasty), Third Edition. J Am Acad Orthop Surg. 2022 May 1;30(9):e721-e729. doi: 10.5435/JAAOS-D-21-01233.

61. Lee JK, Abbas AA, Cheah TE, et al. Topical nonsteroidal anti-inflammatory drugs for management of osteoarthritis pain: A consensus recommendation. J Orthop Res. 2023 Sep;41(9):1916-1924. doi: 10.1002/jor.25549. Epub 2023 Mar 26.

62. Bruyere O, Honvo G, Veronese N, et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum. 2019 Dec;49(3):337- 350. doi: 10.1016/j.semarthrit.2019.04.008. Epub 2019 Apr 30.

63. Nilsen OG. Clinical pharmacokinetics of tenoxicam. Clin Pharmacokinet. 1994 Jan; 26(1):16-43. doi: 10.2165/00003088-199426010-00003.

64. Каратеев АЕ, Алейникова ТЛ. Эйкозаноиды и воспаление. Современная ревматология. 2016;10(4):73-86. doi: 10.14412/1996-7012-2016-4-73-86

65. Каратеев АЕ. Теноксикам. Клиническая фармакология и терапия. 2017;26(5):44-50.

66. Van Antwerpen P, Neve J. In vitro comparative assessment of the scavenging activity against three reactive oxygen species of nonsteroidal anti-inflammatory drugs from the oxicam and sulfoanilide families. Eur J Pharmacol. 2004 Aug 2;496(1-3):55-61.

67. Ferrari GV, Natera J, Paulina Montaсa M. Scavenging of photogenerated ROS by Oxicams. Possible biological and environmental implications. J Photochem Photobiol B. 2015 Dec;153:233-9. doi: 10.1016/j.jphotobiol.2015.09.024. Epub 2015 Sep 28.

68. Ozgocmen S, Ardicoglu O, Erdogan H, et al. In vivo effect of celecoxib and tenoxicam on oxidant/ anti-oxidant status of patients with knee osteoarthritis. Ann Clin Lab Sci. 2005 Spring;35(2):137-43.

69. Бутранова ОИ, Зырянов СК. выбор нестероидных противовоспалительных препаратов для рациональной фармакотерапии хронической скелетно-мышечной боли: взгляд клинического фармаколога. Неврология, нейропсихиатрия, психосоматика. 2024;16(2):87-94. doi: 10.14412/2074-2711-2024-2

70. Cheung LK, Rodrigo C. Tenoxicam for pain relief following third molar surgery. Anesth Pain Control Dent. 1992 Fall;1(4): 229-33.

71. Roelofse JA, Van der Bijl P, Joubert JJ. Analgesic and anti-inflammatory efficacy of tenoxicam and diclofenac sodium after third molar surgery. Anesth Prog. 1996 Fall;43(4): 103-7.

72. Zacharias M, De Silva RK, Herbison P, Templer P. A randomized crossover trial of tenoxicam compared with rofecoxib for postoperative dental pain control. Anaesth Intensive Care. 2004 Dec;32(6):770-4.

73. Arslan H, Topcuoglu HS, Aladag H. Effectiveness of tenoxicam and ibuprofen for pain prevention following endodontic therapy in comparison to placebo: a randomized double-blind clinical trial. J Oral Sci. 2011 Jun; 53(2):157-61.

74. Cebi AT, Kasapoglu MB, Eren S, Kasapoglu C. Comparison of the effects of diclofenac potassium and tenoxicam on postoperative pain, swelling, and trismus following third molar surgery. Turk J Med Sci. 2018 Apr 30;48(2):271-278. doi: 10.3906/sag-1702-100.

75. Kaplan V, Eroglu CN. Comparison of the Effects of Daily Single-Dose Use of Flurbiprofen, Diclofenac Sodium, and Tenoxicam on Postoperative Pain, Swelling, and Trismus: A Randomized Double-Blind Study. J Oral Maxillofac Surg. 2016 Oct;74(10):1946.e1-6. doi: 10.1016/j.joms.2016.05.015. Epub 2016 May 24.

76. Ilhan O, Agacayak KS, Gulsun B, et al. A comparison of the effects of methylprednisolone and tenoxicam on pain, edema, and trismus after impacted lower third molar extraction. Med Sci Monit. 2014 Jan 29;20:147- 52. doi: 10.12659/MSM.890239.

77. Merry AF, Swinburn PF, Middleton NG, et al. Tenoxicam and paracetamol-codeine combination after oral surgery: a prospective, randomized, double-blind, placebo-controlled study. Br J Anaesth. 1998 Dec;81(6): 875-80.

78. Cevik E, Cinar O, Salman N, et al. Comparing the efficacy of intravenous tenoxicam, lornoxicam, and dexketoprofen trometamol for the treatment of renal colic. Am J Emerg Med. 2012 Oct;30(8):1486-90. doi: 10.1016/j.ajem.2011.12.010. Epub 2012 Feb 4.

79. Kekec Z, Yilmaz U, Sözüer E. The effectiveness of tenoxicam vs isosorbide dinitrate plus tenoxicam in the treatment of acute renal colic. BJU Int. 2000 May;85(7):783-5.

80. Al-Waili NS, Saloom KY. Intravenous tenoxicam to treat acute renal colic: comparison with buscopan compositum. J Pak Med Assoc. 1998 Dec;48(12):370-2.

81. Al-Waili NS. Intramuscular tenoxicam to treat acute renal colic. Br J Urol. 1996 Jan; 77(1):15-6.

82. Riedemann PJ, Bersinic S, Cuddy LJ, et al. A study to determine the efficacy and safety of tenoxicam versus piroxicam, diclofenac and indomethacin in patients with osteoarthritis: a meta-analysis. J Rheumatol. 1993 Dec;20(12):2095-103.

83. Langdon CG, Moran DG, Jamieson V, et al. A multicentre study of tenoxicam for the treatment of osteo-arthritis and rheumatoid arthritis in general practice. J Int Med Res. 1990 Nov-Dec;18(6):489-96.

84. Müller P, Dammann HG, Marinis E, Simon B. Gastroduodenal tolerance of tenoxicam versus diclofenac-Na: an endoscopy double-blind controlled study in healthy probands. Z Rheumatol. 1989 Sep-Oct;48(5):243-5.

85. Аl-Quorain AA1, Satti MB, Marwah S, et al. Non-steroidal anti-inflammatory druginduced gastropathy: a comparative endoscopic and histopathological evaluation of the effects of tenoxicam and diclofenac. J Int Med Res. 1993 Mar-Apr;21(2):89-97.

86. Lapeyre-Mestre M, Grolleau S, Montastruc JL. Adverse drug reactions associated with the use of NSAIDs: a case/noncase analysis of spontaneous reports from the French pharmacovigilance database 2002- 2006. Fundam Clin Pharmacol. 2013 Apr; 27(2):223-30. doi: 10.1111/j.1472-8206.2011.00991.x

87. Arfe A, Scotti L, Varas-Lorenzo C, et al. Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study. BMJ. 2016 Sep 28;354:i4857. doi: 10.1136/bmj.i4857.

88. Xu S, Rouzer CA, Marnett LJ. Oxicams, a class of nonsteroidal anti-inflammatory drugs and beyond. IUBMB Life. 2014 Dec; 66(12):803-11. doi: 10.1002/iub.1334. Epub 2014 Dec 23.

89. Wang J, Limburg D, Carter J, et al. Selective inducible microsomal prostaglandin E(2) synthase-1 (mPGES-1) inhibitors derived from an oxicam template. Bioorg Med Chem Lett. 2010 Mar 1;20(5):1604-9. doi: 10.1016/j.bmcl.2010.01.060. Epub 2010 Jan 25.

90. Korotkova M, Jakobsson PJ. Characterization of microsomal prostaglandin E synthase 1 inhibitors. Basic Clin Pharmacol Toxicol. 2014 Jan;114(1):64-9. doi: 10.1111/bcpt.12162. Epub 2013 Nov 11.

91. Kocak AO, Ahiskalioglu A, Sengun E, et al. Comparison of intravenous NSAIDs and trigger point injection for low back pain in ED: A prospective randomized study. Am J Emerg Med. 2019 Oct;37(10):1927-1931. doi: 10.1016/j.ajem.2019.01.015. Epub 2019 Jan 15.

92. Dogan C, Yilmaz A, Ozen M, et al. Comparative evaluation of the effectiveness of intravenous paracetamol, dexketoprofen and ibuprofen in acute low back pain. Am J Emerg Med. 2022 Jun; 56:223-227. doi: 10.1016/j.ajem.2022.04.017. Epub 2022 Apr 14.

93. Colberg K, Hettich M, Sigmund R, Degner FL. The efficacy and tolerability of an 8-day administration of intravenous and oral meloxicam: a comparison with intramuscular and oral diclofenac in patients with acute lumbago. German Meloxicam Ampoule Study Group. Curr Med Res Opin. 1996;13(7):363-77. doi: 10.1185/03007999609111556.

94. Browning RC, Johson K. Reducing the dose of oral NSAIDs by use of Feldene Gel: an open study in elderly patients with osteoarthritis. Adv Ther. 1994 Jul-Aug;11(4): 198-207.

95. Bohl D, Gausmann H, Vorberg G, et al. A clinical trial comparing a new NSAID (droxicam) and piroxicam in spinal osteoarthritis. Int J Clin Pharmacol Ther Toxicol. 1990 Oct;28(10):416-9.

96. Рачин АП, Выговская СН, Нувахова МБ и др. Наблюдательное исследование по оценке эффективности и безопасности теноксикама при дорсалгии в сравнении с мелоксикамом и диклофенаком натрия. Русский медицинский журнал. 2018; 4(II):43-46.

97. Кашеварова НГ, Таскина ЕА, Стребкова ЕА и др. Проспективное сравнительное рандомизированное исследование эффективности и безопасности топических форм теноксикама и диклофенака у пациентов с остеоартритом коленных суставов. Современная ревматология. 2023;17(3):51-59. doi: 10.14412/1996-7012-2023-3

98. Баринов АН, Леонтьева МС, Телышева ЮБ и др. Современные подходы к диагностике и лечению первичной скелетномышечной ноцицептивной боли. Медицинский алфавит. 2023;(2):12-8.